ID

29881

Description

Effect of Pioglitazone on Ambulatory Blood Pressure; ODM derived from: https://clinicaltrials.gov/show/NCT00328393

Link

https://clinicaltrials.gov/show/NCT00328393

Keywords

Versions (1)
  1. 4/25/18 4/25/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 25, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hypertension NCT00328393

English

Eligibility Hypertension NCT00328393

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 45-75 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
diabetes mellitus type 2 (hba1c 7 - 8.5%)
Description

Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement

Data type

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0474680
casual blood pressure > = 130/80 mmhg, < 160/100 mmhg
Description

Blood pressure determination

Data type

boolean

Alias
UMLS CUI [1]
C0005824
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
therapy with insulin
Description

Insulin regime

Data type

boolean

Alias
UMLS CUI [1]
C0557978
combination therapy of sulfonyl-urea und metformin
Description

Combined Modality Therapy | Sulfonylurea | Metformin

Data type

boolean

Alias
UMLS CUI [1]
C0009429
UMLS CUI [2]
C0038766
UMLS CUI [3]
C0025598
therapy with nateglinid, repaglinid or an other substance of this drug family
Description

nateglinide | repaglinide

Data type

boolean

Alias
UMLS CUI [1]
C0903898
UMLS CUI [2]
C0246689
allergy against pioglitazone or other composites of the tablet
Description

Hypersensitivity Pioglitazone | Hypersensitivity Pioglitazone Composite

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0071097
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0071097
UMLS CUI [2,3]
C0205199
history of heart failure (nyha i bis iv)
Description

Heart failure New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C1275491
hepatic insufficiency
Description

Hepatic Insufficiency

Data type

boolean

Alias
UMLS CUI [1]
C1306571
transaminases > 2.5-fold of the upper normal limit
Description

Transaminases increased

Data type

boolean

Alias
UMLS CUI [1]
C0438717
end-stage renal failure
Description

Kidney Failure, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0022661
syndrome of polycystic ovaries
Description

Polycystic Ovary Syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0032460
absence of effective contraception in women of childbearing potential
Description

Childbearing Potential Contraceptive methods Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0332197
pregnancy or breast-feeding
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Back to the top of the page

Similar models

Eligibility Hypertension NCT00328393

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 45-75 years
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement
Item
diabetes mellitus type 2 (hba1c 7 - 8.5%)
boolean
C0011860 (UMLS CUI [1])
C0474680 (UMLS CUI [2])
Blood pressure determination
Item
casual blood pressure > = 130/80 mmhg, < 160/100 mmhg
boolean
C0005824 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Insulin regime
Item
therapy with insulin
boolean
C0557978 (UMLS CUI [1])
Combined Modality Therapy | Sulfonylurea | Metformin
Item
combination therapy of sulfonyl-urea und metformin
boolean
C0009429 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C0025598 (UMLS CUI [3])
nateglinide | repaglinide
Item
therapy with nateglinid, repaglinid or an other substance of this drug family
boolean
C0903898 (UMLS CUI [1])
C0246689 (UMLS CUI [2])
Hypersensitivity Pioglitazone | Hypersensitivity Pioglitazone Composite
Item
allergy against pioglitazone or other composites of the tablet
boolean
C0020517 (UMLS CUI [1,1])
C0071097 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0071097 (UMLS CUI [2,2])
C0205199 (UMLS CUI [2,3])
Heart failure New York Heart Association Classification
Item
history of heart failure (nyha i bis iv)
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Hepatic Insufficiency
Item
hepatic insufficiency
boolean
C1306571 (UMLS CUI [1])
Transaminases increased
Item
transaminases > 2.5-fold of the upper normal limit
boolean
C0438717 (UMLS CUI [1])
Kidney Failure, Chronic
Item
end-stage renal failure
boolean
C0022661 (UMLS CUI [1])
Polycystic Ovary Syndrome
Item
syndrome of polycystic ovaries
boolean
C0032460 (UMLS CUI [1])
Childbearing Potential Contraceptive methods Absent
Item
absence of effective contraception in women of childbearing potential
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Pregnancy | Breast Feeding
Item
pregnancy or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial